SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-023138
Filing Date
2022-06-17
Accepted
2022-06-17 17:12:17
Documents
2
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1662
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4562
  Complete submission text file 0000899243-22-023138.txt   7599
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W. GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address
Drexler Susan L. (Reporting) CIK: 0001821287 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 221024971